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Absfract: We report an autopsy田町 ofpulmonary plexogenic arteriopathy associated 
with portal hypertension due to alcoholic liver cirrhosis， termed portopulmonary 
hypertension (PPHT). A 49-year-old man who has had alcoholic liver cirrhosis for 10 
years complained of severe dyspnea (Fletcher】Hugh-JonesV). Chest CT revealed marked 
enlargement of bilateral hilar pulmonary arteries and cardiomegaly associated with right 
ventricular hypertrophy. The patient died from hepatic. encephalopathy and respiratory 
failure. Autopsy c1early revealed the wall thickness of pulmonary small vessels diffusely 
in periph巴ralfields on cut surfaces and marked dilatation of the main pulmonary artery， 
together with liver cirrhosis. Microscopically， the pulmonary small arteries demonstrated 
grade 5 pulmonary plexogenic arteriopathy inc1uding plexiform lesions and a 
micronodul巴 resemblingan arachnoid granulation or meningioma throughout the lungs. 
This case suggested that a typical plexogenic arteriopathy morphologically and definitely 
contributed to confirm PPHT， although the patient was c1inically suspected of 
hepatopulmonary syndrome (HPS). 
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INTRODUCTlON 
The plexiform lesion is the cardinal histological finding of plexogenic pulmonary 
arteriopathy. The lesion is observed in primary plexogenic pulmonary arteriopathy， 
pulmonary hypertension (PH) secondary to congenital cardiac malformations associated with 
shunting， and the drug aminorex fumarate. Furthermore， itis rarely found with liver 
cirrhosis or portal vein thrombosis. It is well-known that a moderate degree of PH is 
common in patieロtswith portal hypertension due to liver cirrhosis， corresponding to 
morphological change of c1assic plexogenic pulmonary arteriopathyl). The portopulmonary 
hypertension (PPHT) is defined as a pulmonary arterial hypertension associated with portal 
hypertension in the presence or absence of liver disease21 • It was initially reported by Mantz 
and Craige31 in 1951 that the coexistence of PH as a consequence of hepatic dysfunction 
(82) H. Maruyama， et al. 
caused by portal axis thrombosis was found via a postcaval shunt， resulting in cor 
pulmonale. The prevalence is relatively low in PPHT， and its frequency observed to a 
greater extent in alcoholic liver cirrhosis. Especially， the incidence of pulmonary arterial 
hypertension in cases of biopsy-proven liver cirrhosis was between 0.61・2.0%2).
We report here on an autopsy case of plexogenic pulmonary arteriopathy associated with 
alcoholic liver cirrhosis， termed PPHT. Concerning CT findings， the differentiation between 
PPHT and hepatopulmonary syndrome (HPS) isbriefly discussed 
CASE REPORT 
A 49-year-old man complained of severe dyspnea (Fletcher-Hugh-]ones V) and was 
admitted to our hospital because of the marked enlargement of bilateral hilar shadows on 
chest X-ray (Fig. 1). He had a history of heavy alcohol intake (mainly， 5 x 180ml/day x 25 
years of ]apanese Sake) and was diagnosed with alcoholic liver cirrhosis since 10 years 
before. Brinkman index was approximately 400. In the past before admission， he underwent a 
sclerotherapy for esophageal varix. At the time of admission， blood pressure was elevated to 
190/110 mmHg， with pulse rate of 86/min.， respiration rate of 18 times/min， and oxygen 
saturation (Sp02) of 92%. Electrocardiography revealed mild right ventricular hypertrophy 
and right bundle branch block. Echocardiography did not show any cardiac valvular 
abnormality， or clear right ventricular dilatation. His consciousness was somnolent， 
suggesting hepatic encephalopathy of grade I， reflected by high serum ammonia value of 
160μg/dl . The skin appeared icteric. Clubbed finger and flapping tremor were also 
Fig. 1. Chest x-ray showed the enlargement of 
bilateral hilar shadows and elevation of 
cardio-thorax ratio (CTR) 
Fig. 2. Thoracic CT revealed marked enlargement 
of bilateral hilar pulmonary arteries and 
venous dilatated appearance in the 
peripheral lung fields 
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Table 1. Laboratory data on admission 
Blood : RBC 449 X 1041μL， HB 16.4 g/dL， HcT 46.8 %， WBC 71001μL， 
PLT 4.9x 1041μL 
Hemostasis : PT 30.8 sec‘ PT 24.亘弘 rT-INR2.42司 APTT 81.5 sec‘ 
Fibrinogen 82 mg/d，L FDP 6.2μ g/mL 
Biochemistry/lmmuno1ogy : T'Bi1irubin 12.5 mg/dL. D-BIL 5.6 mg/dL. TP 5.2 g/dL. 
A1b 2.6 g/dL. AST 105 IU/L. ALT 57 IU/L. ALP 1243 U/L.γ 幽 GTP 68 U/L. LDH 589 
IU/L. Glucose 131 mg/dL. NH3 160μg/d，L BUN 15.7 mg/dL， Creatinine 0.56 mg/dL， 
Na 140 mEq/L， K 3.0 mEqlL." C1 106 mEq/L， sNP 96.1pg/m，L CRP 0.18 mg/dL， 
HBs-Ag: (一)、 HCV-Ab: (-)， Anti-mitochondria Ab : (-) 
Tumor marker : CEA6.0 ng/m，L，.QA19-9 112.43 U/mL."AFP 14 ng/mL， 
PIVKA-lI 829 mAU/mL， SCCO.5 ng/mL， NSE7.6 ng/mL， sIL-2R 345U瓜![l
Underline: abnormal values 
(83) 
recognized. Laboratory findings are shown in Tab1e 1， and brief1y summarized as thrombo-
cytopenia， decrease in prothrombin time and tota1 protein， increase in tota1 bi1irubin 
(12.5mg/d1)， and HB目Ag，HCV and anti-mitochondria antibody were negative. Tumor markers 
were e1evated as CA19-9 va1ue: 112.4 U Im1， PIVKA -I: 829 and CEA目 6.0(<5.0). Thoracic CT 
revea1ed marked en1argement of bi1atera1 hi1ar pu1monary arteries and right ventricles， and 
moreover marked periphera1 pu1monary veins (Fig. 2). Abdomina1 CT showed liver cirrhosis 
without space occupying 1esion， nor obstruction of porta1 vein， accompanied with 
sp1enomega1y and esophagea1 varices. The clinica1 diagnosis denied 1ung cancer on CT 
findings with negative sputum cyto1ogy， and he was suspected of pu1monary hypertension 
associated with 1iver cirrhosis. B100d gas samp1e was not taken， and right heart 
catheterization was a1so not performed because of a refusa1 by the fami1y. The patient died 
from hepatic encepha10pathy four weeks after admission and was autopsied two hours 1ater. 
PATHOLOGIC FINDINGS AT AUTOPSY 
Gross1y， the 1iver was very small， 630g in weight， and diffuse1y micorgranu1ar in 
approximate1y 3 mm in diameter (Fig. 3). The cut surface did not show any 1iver tumors. 
There were yellowish ascites (600m1)， jaundice， sp1enomega1y (270g) and esophagea1 varices 
with mi1d erosion of gastric cardiac portion. The h巴artweighed 590g， with 100 ml of 
pericardia1 yellowish effusion. There was marked 1eft and right ventricu1ar hypertrophy， 
with the wall thickness of 17 mm (<10 mm in normal) and 8 mm (<5 mm in normal)， 
respective1y. Especially， the girth of PA va1ve in 8cm was 1arger than that of aortic va1ve in 
7cm. The right 1ung weighed 430g and the 1eft 420g， a1most without congestion and 
(84) H. Maruyama， et al. 
Fig. 3. Gross appearance of the liver weighing 630g showed diffuse 
micorgranules in approximately 3 mm in diameter 
Fig. 4. At autopsy， after formalin-fixation， the cut surface of the lung 
showed the wall thickening of small pulmonary arterial vessels 
hemorrhage. There was pleural effusion (rt: 250ml， lt:40白nl).The cut surface of lung clearly 
revealed wall thickness of small blood vessels in the periphery， in addition to enlargement of 
the central pulmonary artery (Fig. 4). The hilar lymph nodes were slightly swollen with 
softness. 
Microscopically， the liver revealed micronodular cirrhosis with only a litle fatty change 
and Mallory body (Fig. 5). Because HBs-Ag and HCV were negative in serum， alcoholic liver 
cirrhosis was considered. The splenomegaly was observed as congestion associated with 
cirrhosis. The cardiac muscles of left and right ventricles were histologically hypertrophic， 
probably due to systemic and PH. In the histologic sections of the lung， the small pulmonary 
arteries from 200 to 500μm mostly demonstrated al types of hypertensive changes， ranging 
from muscular medial hypertrophy (Grade 1 in Heath-Edwards' classification of plexogenic 
pulmonary arteriopathy) to intimal fibrosis (Fig. 6)， plexiform lesions (approximately 300μm 
in diameter) with peripheral dilatation lesions (Grade 4) (Fig. 7) and a micronodule 
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Fig. 5. Microscopicaly， the liver showed pseudolobules， suggesting the alcoholic liver cirrhosis (Masson 
trichrome stain， x20). 
Fig. 6. Microscopicaly， the small pulmonary arteries of approximately 200-300μm demonstrated intimal 
fibrosis (Grade 2-3 in Heath-Edwards' classification) (EVG， x40)， suggesting hypertensive change 
Fig. 7. A small vessel (approximately 300μm in diameter) inthe lung microscopically formed the plexiform 
lesion (Grade 4) with peripheral capillary dilatation (HE， x40) 
Fig. 8. Another smal vessel in the lung microscopically demonstrated a micronodule resembling an 
arachnoid granulation or meningioma (Grade 5) ( HE， xlOO)ー
resembling an arachnoid granulation or meningioma (Grade 5) (Fig. 8). But necrotizing 
arteries of pulmonary arteries (Grade 6) were not observed at histologic sections examined 
In central area， the pulmonary artery demonstrated intimal and medial wal thickness. The 
lymph nodes of pulmonary hilum showed nonspecific findings such as sinus histiocytosis 
and silicoanthracosis， without tumor 
DISCUSSION 
The present case was morphologicaly confirmed to show PPHT associated with non-
compensatory phase of alcoholic liver cirrhosis， although valuable clinical examinations 
concerning on pulmonary hypertension were insufficient， such as a direct pulmonary arterial 
pressure and arterial blood oxygen pressure. That is， plexiform pulmonary arteriopathy was 
considered as the halmark of primary pulmonary hypertension4l (recently re-termed 
(86) H. Maruyama， et al. 
pulmonary arterial hypertension5)). Since the first report by Mantz and Craige3) (aportal 
thrombosis case) in 1951， and subsequently PH complicated by liver cirrhosis was first 
described by NaeyeB) in 1960. PPHT is described in low incidence of 0.61-2%2). In Japan， Ito 
et aF) (1987) reported two autopsy cases of PH in hepatitis B virus-associated liver cirrhosis. 
According to Nakatani et a18)， PPHT of approximately 60 cases have been reported in English 
literature， while 32四 sesin Japan have been reported up to 1985， respectively. Recently， the 
occurrence of PPHT in patients undergoing evaluation for liver transplant has increased as 
high as 8目5%9). It has b巴enreported by Matsubara et aPO) that patients with severe hepatic 
injury (94 adult cases) are in a state of subclinical PH and that symptoms of severe PH may 
develop progressively or abruptly in some of them. They suggested that the wall thickening 
and the ratio of wall thickness to the anatomical radius of small pulmonary art巴neswer巴
significantly larger in the cirrhotic group than in the control group. Edwards et alll) 
described that PH associated with portal hypertension commonly had a plexogenic 
appearance (10 of 12 patients) on histologic sections， and that thrombus might also 
contribute to vascular obstruction. It has been recently described by Dana Point 
classification (2008) that Plexiform pulmonary arteriopathy (P AH) including PPHT has been 
reclassified as an associated type of pulmonary arter包1hypertension (APAH)， together with 
various etiologic disorders， collagen悶vasculardisease， HIV infection， portal hypertension， 
congenital heart disease， schistosomiasis， chronic hemolytic anemia， and drug/toxin such as 
aminorex fumarate. In our case， although portal thrombosis was neither recognized with CT 
imaging or gross findings at autopsy， portal hypertension induced by non-compensatory liver 
cirrhosis with complication of both splenomegaly and esophageal varices was assumed. It 
has been indicated that portal hypertension and portosystemic shunting， rather than the 
hepatic disorder itself including cirrhosis， are most likely to be the determinant risk factor 
for developing PH. 
On the other hand， another pulmonary vascular complication in liver dysfunction， 
hepatopulmonary syndrome (HPS) 12)， is recently important for respiratory clinicians to 
differentiate from PPHT. HPS is defined by liver disease， intrapulmonary vasodilation and 
impaired arterial oxygenation. HPS is usually present with dyspnea without any abnormal 
shadows on chest x-ray， but occasionally with an increase in interstitial markings in the 
lower lung fields on CT imaging. Infrequently， HPS is not easily distinguished from 
portopulmonary hypertension because of similar clinical features， such as dyspnea， anemia， 
ascites， hepatic hydrothorax， and muscle wasting. In our case， oxygen satur・ation(Sp02) was 
lower at 92%， and there was some difficulty before the death in differentiating betw巴en
PPHT and HPS showing the imaging of pulmonary vasodilation in peripheral zone of lung 
on CT13). However， chest x】rayof the present patient showed marked enlargement of bilateral 
hilar shadows and elevation of cardio-thorax ratio (CTR)， suggesting some features of PPHT. 
Microscopically， PPHT shows pulmonary vasoconstriction， intima proliferation， media】
hypertrophy and plexiform lesions， but HPS shows capillary and pre-/post-capillary 
pulmonary vasodilation with lower pulmonary vascular resistance， and right to left shunt 
formation， in spite of fewer autopsy cases. In western countries， orthotopic liver 
transplantation is recently recommended in these two pulmonary vascular complications of 
end-stage liver disease14). It has already been described in 1999 that a case of PPHT following 
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HPS in a patient with liver cirrhosis showed 25】62mmHg of mean pulmonary art巴rypressure 
on right-sided catheterization after more than 2-year clinical course， being still alive15). 
In conclusion， the present case suggests PPHT based on plexogenic pulmonary 
arteriopathy at autopsy associated with non-compensatory alcoholic liver cirrhosis， in spit巴
of clinically differentiating from HPS. The pulmonary complications of end-stage liver 
dis巴aseinclude PPHT and HPS， and the etiologic pathogenesis of these conditions will need 
more elucidation in the near future. 
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